Skip to main navigation Skip to search Skip to main content

Dopamine depletion impairs precursor cell proliferation in Parkinson disease

  • Günter U. Höglinger
  • , Pamela Rizk
  • , Marie P. Muriel
  • , Charles Duyckaerts
  • , Wolfgang H. Oertel
  • , Isabelle Caille
  • , Etienne C. Hirsch
  • AP-HP
  • Philipps-Universität Marburg
  • Ecole Normale Supérieure

Research output: Contribution to journalArticlepeer-review

859 Scopus citations

Abstract

Cerebral dopamine depletion is the hallmark of Parkinson disease. Because dopamine modulates ontogenetic neurogenesis, depletion of dopamine might affect neural precursors in the subependymal zone and subgranular zone of the adult brain. Here we provide ultrastructural evidence showing that highly proliferative precursors in the adult subependymal zone express dopamine receptors and receive dopaminergic afferents. Experimental depletion of dopamine in rodents decreases precursor cell proliferation in both the subependymal zone and the subgranular zone. Proliferation is restored completely by a selective agonist of D2-like (D2L) receptors. Experiments with neural precursors from the adult subependymal zone grown as neurosphere cultures confirm that activation of D2L receptors directly increases the proliferation of these precursors. Consistently, the numbers of proliferating cells in the subependymal zone and neural precursor cells in the subgranular zone and olfactory bulb are reduced in postmortem brains of individuals with Parkinson disease. These observations suggest that the generation of neural precursor cells is impaired in Parkinson disease as a consequence of dopaminergic denervation.

Original languageEnglish
Pages (from-to)726-735
Number of pages10
JournalNature Neuroscience
Volume7
Issue number7
DOIs
StatePublished - Jul 2004
Externally publishedYes

Fingerprint

Dive into the research topics of 'Dopamine depletion impairs precursor cell proliferation in Parkinson disease'. Together they form a unique fingerprint.

Cite this